OBJECTIVES: To evaluate the risk factors for perioperative complications among patients undergoing craniofacial resection for the treatment of skull base tumors. DESIGN: Retrospective analysis. PARTICIPANTS: The study group comprised 29 patients with skull base tumors (22 malignant and 7 benign) who underwent 30 craniofacial resections at Hokkaido University Hospital between 1989 and 2006. Of these cases, 21 had undergone prior treatment by radiation (16 cases), surgery (7 cases), or chemotherapy (1 case). Moreover, 19 needed extended resection involving the dura (11 cases), brain (5 cases), orbit (12 cases), hard palate (5 cases), skin (3 cases), or cavernous sinus (2 cases). MAIN OUTCOME MEASURES: Perioperative complications and risk factor associated with their incidence. RESULTS: Perioperative complications occurred in 12 patients (40%; 13 cases). There was a significant difference between complication rates for cases with and without prior therapy (52.4% vs. 11.1%). The complication rate for dural resection cases was 81.8%. There was a significant difference between complication rates for cases with and without dura resection. No postoperative mortality was reported. CONCLUSIONS: Craniofacial resection is a safe and effective treatment for skull base tumors. However, additional care is required in patients with extended resection (especially dural) and those who have undergone prior therapy.
OBJECTIVES: To evaluate the risk factors for perioperative complications among patients undergoing craniofacial resection for the treatment of skull base tumors. DESIGN: Retrospective analysis. PARTICIPANTS: The study group comprised 29 patients with skull base tumors (22 malignant and 7 benign) who underwent 30 craniofacial resections at Hokkaido University Hospital between 1989 and 2006. Of these cases, 21 had undergone prior treatment by radiation (16 cases), surgery (7 cases), or chemotherapy (1 case). Moreover, 19 needed extended resection involving the dura (11 cases), brain (5 cases), orbit (12 cases), hard palate (5 cases), skin (3 cases), or cavernous sinus (2 cases). MAIN OUTCOME MEASURES: Perioperative complications and risk factor associated with their incidence. RESULTS: Perioperative complications occurred in 12 patients (40%; 13 cases). There was a significant difference between complication rates for cases with and without prior therapy (52.4% vs. 11.1%). The complication rate for dural resection cases was 81.8%. There was a significant difference between complication rates for cases with and without dura resection. No postoperative mortality was reported. CONCLUSIONS:Craniofacial resection is a safe and effective treatment for skull base tumors. However, additional care is required in patients with extended resection (especially dural) and those who have undergone prior therapy.
Entities:
Keywords:
Complications; craniofacial resection; skull base surgery
Authors: Ian Ganly; Snehal G Patel; Bhuvanesh Singh; Dennis H Kraus; Patrick G Bridger; Giulo Cantu; Anthony Cheesman; Geraldo De Sa; Paul Donald; Dan Fliss; Patrick Gullane; Ivo Janecka; Shin-etsu Kamata; Luiz P Kowalski; Paul Levine; Luiz R Medina; Sultan Pradhan; Victor Schramm; Carl Snyderman; William I Wei; Jatin P Shah Journal: Head Neck Date: 2005-06 Impact factor: 3.147
Authors: Snehal G Patel; Bhuvanesh Singh; Ashok Polluri; Patrick G Bridger; Giulio Cantu; Anthony D Cheesman; Geraldo M deSa; Paul Donald; Dan Fliss; Patrick Gullane; Ivo Janecka; Shin-Etsu Kamata; Luiz P Kowalski; Dennis H Kraus; Paul A Levine; Luiz R M dos Santos; Sultan Pradhan; Victor Schramm; Carl Snyderman; William I Wei; Jatin P Shah Journal: Cancer Date: 2003-09-15 Impact factor: 6.860
Authors: Ana Kober N Leite; Gustavo Fernandes de Alvarenga; Sérgio Gonçalves; Alexandre Bezerra Dos Santos; Hugo Sterman Neto; Claudio R Cernea; Marco Aurélio V Kulcsar; Luiz Paulo Kowalski; Leandro Luongo Matos Journal: Clinics (Sao Paulo) Date: 2021-05-21 Impact factor: 2.365
Authors: Sonam Dodhia; Conall W R Fitzgerald; Andrew T McLean; Avery Yuan; Cristina Valero Mayor; Dauren Adilbay; Ximena Mimica; Piyush Gupta; Jennifer R Cracchiolo; Snehal Patel; Richard J Wong; Jatin Shah; Ian Ganly; Marc A Cohen Journal: J Surg Oncol Date: 2021-07-08 Impact factor: 2.885